Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China

被引：0
|
作者：
Xiaoyu Yan
Xiaohua Gu
Zhenxing Xu
Houweng Lin
Bin Wu
机构：
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Orthopedics
[2] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Respiratory Medicine
[3] Shanghai Jiaotong University,Department of Cardiology, Renji Hospital, South Campus, School of Medicine
[4] Shanghai Jiaotong University,Medical Decision and Economic Group, Department of Pharmacy, Renji Hospital, School of Medicine
来源：
Advances in Therapy | 2017年 / 34卷
关键词：
Anticoagulation; Cardiology; Cost-effectiveness analysis; Venous thromboembolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：466 / 480
页数：14
相关论文
共 50 条
  • [21] Cost-effectiveness of apixaban prophylaxis for venous thromboembolism (VTE) in total knee and hip replacement (TKR/THR)
    Rublee, D.
    Simon, T.
    Migliaccio-Walle, K.
    Merikle, E.
    Caro, J.
    Marchant, N.
    Drost, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 194 - 194
  • [22] Cost-Effectiveness of Venous Thromboembolism Prophylaxis With a New Mobile Device After Total Hip Arthroplasty
    Colwell, Clifford W., Jr.
    Froimson, Mark I.
    Mont, Michael A.
    Ritter, Merrill A.
    Trousdale, Robert T.
    Buehler, Knute C.
    Spitzer, Andrew I.
    Donaldson, Thomas K.
    Padgett, Douglas E.
    JOURNAL OF ARTHROPLASTY, 2012, 27 (08): : 1513 - 1517
  • [23] COST ANALYSIS OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AFTER TOTAL KNEE REPLACEMENT AND TOTAL HIP REPLACEMENT
    Marmarali, B.
    Altintas, F.
    Bal, K.
    Bozkurt, K.
    Demir, M.
    Erdemli, B.
    Ince, B.
    Ongen, G.
    Deger, C.
    Parali, E.
    Saka, G.
    Koksal, T.
    Yuvakuran, M.
    VALUE IN HEALTH, 2012, 15 (04) : A119 - A119
  • [24] COST EFFECTIVENESS ANALYSIS APIXABAN IN THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP OR KNEE REPLACEMENT IN ADULTS IN COSTA RICA IN 2015
    Peralta-Acon, M.
    Poveda-Fernandez, J.
    VALUE IN HEALTH, 2016, 19 (03) : A48 - A48
  • [25] COST-EFFECTIVENESS ANALYSIS OF ENOXAPARIN FOR EXTENDED THROMBOPROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) AFTER ELECTIVE TOTAL HIP REPLACEMENT (THR) SURGERY
    Weitz, J.
    Bernard, L.
    Wakeford, C.
    VALUE IN HEALTH, 2009, 12 (07) : A333 - A333
  • [26] COST-EFFECTIVENESS OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AFTER TOTAL KNEE AND HIP REPLACEMENT FROM THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM PERSPECTIVE
    Alexandre, R. F.
    Santana, C. F.
    Squiassi, H. B.
    Nascimento, R.
    Lucchetta, R.
    Riveros, B. S.
    Rosim, M. P.
    Pedro, G. O.
    Nita, M. E.
    VALUE IN HEALTH, 2017, 20 (05) : A32 - A32
  • [27] Prevention of Venous Thromboembolism in Total Knee and Hip Replacement
    Warwick, David
    CIRCULATION, 2012, 125 (17) : 2151 - 2155
  • [28] Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain
    Monreal, Manuel
    Folkerts, Kerstin
    Diamantopoulos, Alex
    Imberti, Davide
    Brosa, Max
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (05) : 987 - 994
  • [29] MODEL SENSITIVITY ANALYSIS OF VENOUS THROMBOEMBOLISM PREVENTION AFTER TOTAL HIP REPLACEMENT
    Vorobiev, P.
    Krasnova, L.
    Shustov, A.
    Bashlakova, E.
    VALUE IN HEALTH, 2012, 15 (07) : A369 - A369
  • [30] PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM IN HIP FRACTURE SURGERY - TOTAL COSTS AND COST-EFFECTIVENESS IN THE NETHERLANDS
    MOL, WEM
    EGBERTS, TCG
    PHARMACOECONOMICS, 1994, 5 (01) : 48 - 55
12345